Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HAVN Life Sciences Inc C.HAVN

Alternate Symbol(s):  HAVLF

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. The Company has two business divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. Through its research division, HAVN Labs, it has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research. The HAVN Retail division formulates and sells natural health products (NHPs) using compounds. It offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.


CSE:HAVN - Post by User

HAVN Life Sciences Inc > News Update w Radius Research and $HAVN CEO Tim Moore
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by oilfiftybuckson Mar 07, 2022 11:45am
494 Views
Post# 34490801

RE:RE:News Update w Radius Research and $HAVN CEO Tim Moore

RE:RE:News Update w Radius Research and $HAVN CEO Tim MooreSomething strange going on. Price was 0.125 the day they announced share sale. Price drops to .05 before share sale closed. 2 days later share sale closes for $2mm cash injection at .087 per share and still the share price is dipping down to 0.045. Interesting to note that no insiders buying at these depressed prices. Anybody know the short position on this dog?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities